Summary
Rats were administered haloperidol (3–4 mg/kg/day) in their drinking water for 42 days, and experiments conducted on the seventh day of withdrawal. Anaesthetized haloperidol treated rats exhibited a similar mean blood pressure (BP) and heart rate (HR) response to control rats when challenged with phenylephrine (IV). When similarly pretreated rats were challenged with one of four possible doses of clonidine (IV), haloperidol treated rats were less sensitive than control rats to clonidine's hypertensive action, but there were no effects of treatment on the hypotensive (BP) effect of clonidine nor on its bradycardic effect. When one of six possible doses of tyramine was administered a similar mean BP response was seen in both treatment groups, but the positive HR response in the haloperidol-treated group was much less than in the vehicle-treated group. Atria isolated from haloperidol treated or control rats revealed a similar chronotropic response to noradrenaline and tyramine challenge. These data indicate that chronic haloperidol does not cause a generalized change inα-adrenergic receptor sensitivity. Nevertheless, it is clear that haloperidol has produced changes in the cardiovascular response of rats to these drugs.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Andén, N. E., Butcher, S. G., Corrodi, H., Fuxe, K., Ungerstedt: Receptor activity and turnover of dopamine and noradrenaline after neuroleptics. Eur. J. Pharmacol.11, 303–314 (1970).
Bentley, G. A., Copeland, I. W.: The nature of centralα-receptors modulated by chronic haloperidol treatment in cats. Proc. Aust. Soc. Clin. Exp. Pharmacol., December, 1981, Abstract 99.
Bousquet, P., Gaertner, M., Feldman, J., Bloch, R.: Variations en fonction de l'anesthesique, des effects de la clonidine sur la pression arterielle du rat. Biol. Comptes rendus5, 1129–1133 (1977).
Bousquet, P., Guertzenstein, P. G.: Localization of the central cardiovascular action of clonidine. Brit. J. Pharmacol.49, 573–579 (1973).
Carlsson, A., Rosengren, E., Bertler, A., Nilsson, J.: Effect of reserpine on the metabolism of catecholamines. In: Psychotropic Drugs (Garattini, S., Ghetti, V., eds.), Vol. 6, pp. 363–372. Amsterdam: Elsevier. 1957.
Drew, G. M.: Effects ofα-adrenoceptor agonists and antagonists on pre- and post-synaptically locatedα-adrenoceptors. Eur. J. Pharmacol.36, 313–320 (1976).
Dunstan, R., Jackson, D. M.: The demonstration of a change in adrenergic receptor sensitivity in the central nervous system of mice after with drawal from long-term treatment with haloperidol. Psychopharmacol.48, 105–114 (1976).
Dunstan, R., Jackson, D. M.: The demonstration of a change in responsiveness of mice to physostigmine after withdrawal from long-term haloperidol pretreatment. J. Neural Transm.40, 181–189 (1977 a).
Dunstan, R., Jackson, D. M.: The effect of apomorphine and clonidine on locomotor activity in mice after long-term treatment with haloperidol. Clin. Exp. Pharmacol. Physiol.4, 131–141 (1977 b).
Dunstan, R., Jackson, D. M.: Further evidence for a change in alpha-adrenergic receptor sensitivity after withdrawal from long-term haloperidol treatment. Naunyn-Schmiedeberg's Arch. Pharmacol.303, 153–156 (1978).
Dunstan, R., Jackson, D. M.: Long-term haloperidol-treatment of mice: a change inβ-adrenergic receptor responsiveness. J. Neural Transm.44, 187–195 (1979).
Ettenberg, A., Milner, P. M.: Effects of dopamine supersensitivity on lateral hypothalamic self-stimulation in rats. Pharmacol. Biochem. Behav.7, 507–514 (1977).
Gianutsos, G., Lal, H.: Alteration in the action of cholinergic and anticholinergic drugs after chronic haloperidol: indirect evidence for cholinergic hyposensitivity. Life Sciences18, 515–520 (1976).
Jackson, D. M., Bailey, R. C., Christie, M. J., Crisp, E. A., Skerritt, J. H.: Long-term d-amphetamine in rats: lack of a change in post-synaptic dopamine receptor sensitivity. Psychopharmacol.73, 276–280 (1981).
Jackson, D. M., Dunstan, R., Bracs, P. U.: Pharmacological models in tardive dyskinesia: a role for dopamine and noradrenaline. In: Symposium on Drugs and Society (Johnson, G. F. S., ed.), pp. 13–21. Sydney: Ciba Geigy. 1976.
Kobinger, W., Walland, A.: Circulatory studies with 2-(2,6-dichlorophenyl-amino)-2-imidazoline hydrochloride. Arzneim.-Forsch.17, 292–300 (1967).
McGrath, J. C.: Evidence for more than one type of post-junctional alpha-adrenoceptor. Biochem. Pharmacol.15, 467–484 (1982).
Misra, C. H., Shelat, H., Smith, R. C.: Influence of age on the effects of chronic fluphenazine on receptor binding in rat brain. Eur. J. Pharmacol.76, 317–324 (1981).
Nayler, W. G., Price, J. M., Swann, J. B., McInnes, I., Race, D., Lowe, T. F.: Effect of the hypotensive drug St-155 (Catapres) on the heart and peripheral circulation. J. Pharmacol. exp. Ther.164, 45–59 (1968).
Pharmacological Experiments on Isolated Preparations, by The Staff of the Department of Pharmacology, University of Edinburgh. Edinburgh: Livingstone. 1970.
Schelkunov, E. L.: Adrenergic effect of chronic administration of neuro-leptics. Nature214, 1210–1212 (1967).
Schmitt, H.: The pharmacology of clonidine. In: Antihypertensive Agents (Gross, F., ed.), Vol. 39, pp. 299–396. Berlin-Heidelberg-New York: Springer. 1977.
Schmitt, H., Schmitt, H.: Interactions between 2-(2,6-dichlorophenylamino)-2-imidazoline hydrochloride (St 155, Catapresan) andα-adrenergic blocking drugs. Eur. J. Pharmacol.9, 7–13 (1970).
Schmitt, H., Schmitt, H. F. S.: Evidence for anα-sympathomimetic component in the effects of catapresan on vasomotor centres: antagonism by piperoxan. Eur. J. Pharmacol.14, 98–100 (1971).
Starke, K., Endo, T., Taube, H.: Relative pre- and post-synaptic potencies ofα-adrenoceptor agonists in the rabbit pulmonary artery. Naunyn-Schmiedeberg's Arch. Pharmacol.291, 55–78 (1975).
Tarsy, D., Baldessarini, R. J.: Behavioural supersensitivity to apomorphine following chronic treatment with drugs which interfere with the synaptic function of catecholamines. Neuropharmacol.13, 927–940 (1974).
Winer, B. J.: Statistical Principles in Experimental Design, 2nd ed. Tokyo: McGraw-Hill, Kogakusha. 1971.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Perrington, A., Einstein, R., Jackson, D.M. et al. Chronic haloperidol and adrenergic receptor sensitivity in the rat. J. Neural Transmission 57, 13–25 (1983). https://doi.org/10.1007/BF01250044
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF01250044